Toffoli G - Search Results

1

Effect of cyclosporine on teniposide pharmacokinetics and pharmacodynamics in patients with renal cell cancer.

Gigante M, Sorio R, Colussi AM, Sandrin A, De Appollonia L, Galligioni E, Freschi A, Talamini R, Toffoli G, Boiocchi M. Gigante M, et al. Among authors: toffoli g. Anticancer Drugs. 1995 Jun;6(3):479-82. doi: 10.1097/00001813-199506000-00019. Anticancer Drugs. 1995. PMID: 7670149 Clinical Trial.

2

Mechanism of multidrug resistance in human tumour cell lines and complete reversion of cellular resistance.

Boiocchi M, Toffoli G. Boiocchi M, et al. Among authors: toffoli g. Eur J Cancer. 1992;28A(6-7):1099-105. doi: 10.1016/0959-8049(92)90465-e. Eur J Cancer. 1992. PMID: 1352696

3

P-glycoprotein but not topoisomerase II and glutathione-S-transferase-pi accounts for enhanced intracellular drug-resistance in LoVo MDR human cell lines.

Boiocchi M, Tumiotto L, Giannini F, Viel A, Biscontin G, Sartor F, Toffoli G. Boiocchi M, et al. Among authors: toffoli g. Tumori. 1992 Jun 30;78(3):159-66. doi: 10.1177/030089169207800303. Tumori. 1992. PMID: 1359686

4

Expression of glutathione-S-transferase-pi in human tumours.

Toffoli G, Viel A, Tumiotto L, Giannini F, Volpe R, Quaia M, Boiocchi M. Toffoli G, et al. Eur J Cancer. 1992;28A(8-9):1441-6. doi: 10.1016/0959-8049(92)90540-i. Eur J Cancer. 1992. PMID: 1515267

5

Expression of the mdr1 gene in human colorectal carcinomas: relationship with multidrug resistance inferred from analysis of human colorectal carcinoma cell lines.

Toffoli G, Viel A, Tumiotto L, Maestro R, Biscontin G, Boiocchi M. Toffoli G, et al. Cancer Chemother Pharmacol. 1992;29(4):283-9. doi: 10.1007/BF00685946. Cancer Chemother Pharmacol. 1992. PMID: 1537074

6

Expression of MDR1 and GST-pi in human soft tissue sarcomas: relation to drug resistance and biological aggressiveness.

Toffoli G, Frustaci S, Tumiotto L, Talamini R, Gherlinzoni F, Picci P, Boiocchi M. Toffoli G, et al. Ann Oncol. 1992 Jan;3(1):63-9. doi: 10.1093/oxfordjournals.annonc.a058073. Ann Oncol. 1992. PMID: 1606072

7

Pleiotropic-resistant phenotype is a multifactorial phenomenon in human colon carcinoma cell lines.

Toffoli G, Viel A, Tumiotto L, Biscontin G, Rossi C, Boiocchi M. Toffoli G, et al. Br J Cancer. 1991 Jan;63(1):51-6. doi: 10.1038/bjc.1991.11. Br J Cancer. 1991. PMID: 1671208 Free PMC article.

8

Frequent occurrence of Ha-rasl allelic deletion in human ovarian adenocarcinomas.

Viel A, De Pascale L, Toffoli G, Tumiotto L, Miotto E, Boiocchi M. Viel A, et al. Among authors: toffoli g. Tumori. 1991 Feb 28;77(1):16-20. doi: 10.1177/030089169107700104. Tumori. 1991. PMID: 1708177

9

c-myc overexpression is a tumor-specific phenomenon in a subset of human colorectal carcinomas.

Viel A, Maestro R, Toffoli G, Grion G, Boiocchi M. Viel A, et al. Among authors: toffoli g. J Cancer Res Clin Oncol. 1990;116(3):288-94. doi: 10.1007/BF01612905. J Cancer Res Clin Oncol. 1990. PMID: 2196264

10

In K562 leukemia cells treated with doxorubicin and hemin, a decrease in c-myc mRNA expression correlates with loss of self-renewal capability but not with erythroid differentiation.

Toffoli G, Viel A, Bevilacqua C, Maestro R, Tumiotto L, Boiocchi M. Toffoli G, et al. Leuk Res. 1989;13(4):279-87. doi: 10.1016/0145-2126(89)90064-7. Leuk Res. 1989. PMID: 2654492

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

352 results

Search Page

Filters